Ruthless Prioritization and How it Can Help Every Medtech Startup: Interview with Paul Buckman, Former CEO of Conventus, SentreHEART, and Pathway Medical Technologies

A few years ago, I had the privilege of sitting down and talking with serial medtech entrepreneur Paul Buckman, who at the time, was CEO of Conventus Orthopedics.

Prior to Conventus, Paul held CEO roles at SentreHEART, Pathway Medical Technologies (which sold to Bayer HealthCare), and Devax (which sold to Biosensors International). From 2004 through 2006, Buckman served as President of the Cardiology Division of St. Jude Medical.

Before joining St. Jude, he served as Chairman and CEO of ev3, a company that Buckman co-founded and was later acquired by Covidien for $2.5 billion dollars in 2010.

Paul has worked in the medical device industry for over 35 years, including 10 years at Scimed Life Systems and Boston Scientific, where he held several executive positions before becoming President of the Cardiology Division at Boston Scientific in January of 2000. Buckman received a BA degree in business administration and an MBA degree from Western Michigan University.

Interview Highlights with Paul Buckman

  • Of all the medtech startups that Paul’s been a part of, the two that are closest to his heart.
  • Two of the many key learnings that Paul recalls during his time helping to build Scimed.
  • When it comes to product development for medical device startups, why it’s critical to be ruthless about prioritization.
  • Paul’s rationale for making the leap from president of Boston Scientific’s cardiology business to starting ev3 in the early 2000’s.
  • Paul’s approach to turning around medtech startups that have hit a wall.
  • Paul’s advice for raising capital for medical device startups.
  • Paul’s favorite business book, the CEO he most admires, and the advice he’d give to his 30-year-old self.

Listen to the Interview with Paul Buckman

Read the Interview with Paul Buckman

Download a copy of the interview transcript right here.

You May Like These Articles

  • Recent
  • Featured
  • Related

How to Navigate Clinical Trials and Fundraising Challenges: Interview With Eyevensys CEO Patricia Zilliox

CEO of Eyevensys Patricia Zilliox gives her best advice for navigating drug and device development, including how to manage a long timeline in clinical trials, choosing an indication to design your device around, and why fundraising is the hardest part of her job.

From Investor Pitch to Eventual Partnership: Interview With HealthQuest Capital Founder Garheng Kong

HealthQuest Capital founder and managing partner Garheng Kong shares advice for entrepreneurs looking to fund their healthcare businesses. He discusses the value of a warm introduction, why some businesses aren’t a good fit for VC investors, and shares the sweet spot for syndication.

How To Launch Your Medical Device With a Global Perspective: Interview With Lightpoint Medical CEO Graeme Smith

Lightpoint Medical’s CEO, Graeme Smith, discusses strategies for medech commercial launches. He shares best practices for activating the key players when bringing new devices to market: payers, distributors, and investors.

Why Your Medical Device Company Needs Different Value Props For Different Stakeholders: Interview With Steve Anderson, Co-Founder and CEO of Preceptis Medical

Preceptis Medical CEO Steve Anderson explains how to keep all of your stakeholders in mind from the start, why having a voice of experience can help you navigate the process of getting to market, and why you should check and recheck your study protocols.

Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.

Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger

In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.

Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market

In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.

How to Navigate Clinical Trials and Fundraising Challenges: Interview With Eyevensys CEO Patricia Zilliox

CEO of Eyevensys Patricia Zilliox gives her best advice for navigating drug and device development, including how to manage a long timeline in clinical trials, choosing an indication to design your device around, and why fundraising is the hardest part of her job.

From Investor Pitch to Eventual Partnership: Interview With HealthQuest Capital Founder Garheng Kong

HealthQuest Capital founder and managing partner Garheng Kong shares advice for entrepreneurs looking to fund their healthcare businesses. He discusses the value of a warm introduction, why some businesses aren’t a good fit for VC investors, and shares the sweet spot for syndication.

How To Launch Your Medical Device With a Global Perspective: Interview With Lightpoint Medical CEO Graeme Smith

Lightpoint Medical’s CEO, Graeme Smith, discusses strategies for medech commercial launches. He shares best practices for activating the key players when bringing new devices to market: payers, distributors, and investors.

Why Your Medical Device Company Needs Different Value Props For Different Stakeholders: Interview With Steve Anderson, Co-Founder and CEO of Preceptis Medical

Preceptis Medical CEO Steve Anderson explains how to keep all of your stakeholders in mind from the start, why having a voice of experience can help you navigate the process of getting to market, and why you should check and recheck your study protocols.